Breaking News

Coldstream Names FormDev Director

By Gil Roth | November 18, 2013

Raiche to lead process, product development teams

Adrian Raiche, Ph.D. has been named director of Formulation Development at Coldstream Laboratories, Inc. In this position, Dr. Raiche will head the formulation development group at Coldstream and will oversee teams focusing on process and product development, lyophilization and scale-up activities for manufacturing in the company's sterile manufacturing facility.

Dr. Raiche brings to Coldstream expertise in numerous aspects of pharma development, particularly lyophilization and potent compound handling. Most recently, he served as manager of Pharmaceutical Development at Summit Biosciences contributing to formulation, analytical and process development of nasal spray products. Prior experience includes tenures at SiO2 Medical Products, Brookwood Pharmaceuticals and Bausch and Lomb.

"We are pleased with Dr. Raiche's addition to the Coldstream team," said Coldstream's president and chief executive officer, Eric Smart. "His knowledge of process and product development enhances Coldstream's focus on the development of parenterals, especially our emphasis on highly active compounds."
blog comments powered by Disqus
  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • DCAT Week ’16 Session Highlights

    Kristin Brooks, Contract Pharma||March 24, 2016
    API and Dose CMO Market Trends and Supply Strategies

  • Talking Trends with Aesica

    Talking Trends with Aesica

    Tim Wright, editor||February 26, 2016
    Managing director Ian Muir fills us in on the latest at the CDMO